Breaking Down Xiamen ITG Group Corp.,Ltd Financial Health: Key Insights for Investors

Investors watching Xiamen ITG Group Corp.,Ltd (600755.SS) will find a mix of worrying declines and bright spots in the numbers: first-quarter 2025 revenue fell to 70.534 billion yuan (‑27.19% YoY) after 2024 full-year revenue slid to 354.44 billion yuan (‑24.30%), driven by weakness in its core supply‑chain management business even as the health technology arm surged 49.61% to contribute 1.10 billion yuan; profitability shows volatility with Q1 2025 net income of 422 million yuan (+2.76% YoY) versus a 2024 net income plunge to 76.99 million yuan (‑95.98%), TTM net income at 88.33 million yuan and diluted EPS of 0.03 yuan, while operating margin is a thin 1.15%, ROA is negative at ‑0.06% and ROE only 0.44%; balance‑sheet and valuation metrics paint a complex picture-total assets of 16.53 billion dollars against total debt of 3.39 billion dollars, enterprise‑value-to‑revenue of 0.08 and an EV/EBITDA of 75.13, market capitalization at 13.85 billion yuan with the stock trading at 6.48 yuan (consensus target 7.50 yuan), free cash flow of 16.8 billion yuan, cash of 151.779 million yuan as of June 30, 2025, and revenue per employee of 44.62 million yuan-read on to unpack what these figures mean for risk, valuation and potential growth opportunities.

Xiamen ITG Group Corp.,Ltd (600755.SS) - Revenue Analysis

• Q1 2025 revenue: 70.534 billion yuan, down 27.19% year-on-year.
• FY 2024 revenue: 354.44 billion yuan, down 24.30% year-on-year.
• Primary cause: reduced demand in supply chain management (the largest revenue contributor).
• Health technology segment: 49.61% growth in 2024, contributing 1.10 billion yuan.
• Revenue per employee: 44.62 million yuan - indicating high per-head productivity.
• Market capitalization (as of 2025-12-12): 13.85 billion yuan, down 5.40% over the prior year.

• Impacted segments: Supply chain management - primary driver of the revenue decline due to weaker end-market demand and lower logistics/transaction volumes.
• Offsetting strengths: Health technology expansion (49.61% growth) and high revenue per employee suggest operational efficiency and potential for margin support if revenues stabilize.
• Investor reference: Exploring Xiamen ITG Group Corp.,Ltd Investor Profile: Who's Buying and Why?

Xiamen ITG Group Corp.,Ltd (600755.SS) - Profitability Metrics

Key profitability figures for Xiamen ITG Group Corp.,Ltd (600755.SS) show a mixed short-term recovery amid a weak 2024 fiscal year and low operational efficiency over the trailing twelve months (TTM).

• Q1 2025 net income: 422 million yuan, up 2.76% year-on-year.
• FY 2024 net income: 76.99 million yuan, a decline of 95.98% vs. FY 2023.
• TTM net income: 88.33 million yuan; TTM diluted EPS: 0.03 yuan.
• TTM operating margin: 1.15% - low operational profitability.
• TTM ROA: -0.06% - negative return on assets.
• TTM ROE: 0.44% - modest return to shareholders.

These metrics indicate near-term improvement in quarterly earnings but a deep 2024 earnings collapse and weak TTM margins and returns, factors investors should weigh alongside growth prospects, balance sheet strength and strategic initiatives. For the company's guiding principles and strategic direction, see Mission Statement, Vision, & Core Values (2026) of Xiamen ITG Group Corp.,Ltd.

Xiamen ITG Group Corp.,Ltd (600755.SS) - Debt vs. Equity Structure

• Low balance-sheet leverage: debt-to-equity ≈ 0.205, indicating debt is about 20.5% of equity (measured via assets and debt figures reported).
• Market cap (12‑Dec‑2025): ¥13.85 billion - a 5.40% decline year-over-year, reflecting modest negative market momentum.
• Concentrated loan composition: short-term loans ¥3.691 billion; long-term loans ¥1.955 billion.
• Contingent support: controlling shareholder ITG Holding has committed support to ensure going-concern stability for at least the next 12 months.
• Valuation signals: EV/Revenue = 0.08 and EV/EBITDA = 75.13, implying a low enterprise value relative to revenue but a very high EV multiple on operating cash-profit metrics.

• Implication: the low debt-to-equity ratio reduces solvency risk but the large short-term loan balance (¥3.691B) increases near-term liquidity dependence.
• Implication: EV/Revenue of 0.08 suggests the market values the company at a small fraction of sales, while EV/EBITDA of 75.13 signals either depressed EBITDA or market-implied caution on future earnings.
• Implication: shareholder support mitigates immediate going-concern risk but does not replace the need to monitor cash flows, refinancing of short-term debt, and EBITDA trends.

Xiamen ITG Group Corp.,Ltd (600755.SS) - Liquidity and Solvency

Key liquidity and solvency indicators for Xiamen ITG Group Corp.,Ltd (600755.SS) show mixed signals: very strong free cash flow for FY ending 31 Mar 2025, recent growth in cash balances, but pressured profitability and weak returns on assets and equity on a trailing twelve months (TTM) basis.

• Free cash flow (FY ended 2025-03-31): 16.8 billion yuan - robust operational cash generation.
• Cash and cash equivalents: 151.779 million yuan as of 2025-06-30, up from 7.609 million yuan as of 2024-12-31.
• Net income (FY ended 2024-12-31): 625.66 million yuan, down 67.3% year-over-year.
• Operating margin (TTM): 1.15% - low operating efficiency.
• Return on assets (ROA, TTM): -0.06% - assets are not generating positive returns.
• Return on equity (ROE, TTM): 0.44% - modest shareholder return.

• Interpretation: large free cash flow provides a liquidity buffer despite compressed earnings; recent cash balance rebound reduces near-term liquidity risk.
• Risks: very low operating margin and negative ROA signal ongoing profitability and asset-utilization challenges that could pressure solvency if trends persist.
• Monitoring items: sustainability of FCF, trend in operating margin, asset turnover, and any changes to debt levels or working capital needs.

Related reading: Exploring Xiamen ITG Group Corp.,Ltd Investor Profile: Who's Buying and Why?

Xiamen ITG Group Corp.,Ltd (600755.SS) Valuation Analysis

Key valuation metrics for Xiamen ITG Group Corp.,Ltd (600755.SS) provide a stark picture of how the market is pricing the company relative to revenue, book value and cash‑flow proxies. Below are the most recent trailing twelve months (TTM) figures and market price context.

• P/S of 0.05: investors are valuing each yuan of annual revenue at ~0.05 yuan - implies either very low margins, significant non-operating liabilities, or market neglect.
• P/B of 0.65: market values the firm at a discount to its stated net assets, offering a margin relative to balance-sheet backing.
• EV/Revenue of 0.08 vs EV/EBITDA of 75.13: the divergence suggests reported EBITDA is very small or near zero (or negative adjustments), inflating EV/EBITDA despite low EV-to-sales.
• Consensus target (7.50 yuan) vs market price (6.48 yuan): ~15.7% upside per analyst mean, but priced with unusually low revenue multiples.

Factors investors should cross-check when interpreting these metrics:

• Recent EBITDA trend and one-off items - reconcile why EV/EBITDA is extremely high while EV/Revenue is very low.
• Balance-sheet quality - confirm tangible book value, asset impairments, and off‑balance liabilities that affect P/B relevance.
• Revenue recognition and margin sustainability - low P/S can indicate either undervaluation or structurally thin margins.
• Market liquidity and share float - thin trading can produce volatile pricing versus fundamentals.

For broader corporate context and historical perspective, see: Xiamen ITG Group Corp.,Ltd: History, Ownership, Mission, How It Works & Makes Money

Xiamen ITG Group Corp.,Ltd (600755.SS) - Risk Factors

• Revenue decline: reported a 24.30% decrease in 2024 vs. 2023, signaling shrinking top-line traction and pressure on cash flow coverage.
• Profitability collapse: net income fell 95.98% in 2024 vs. the prior year, reflecting severe margin compression and potential one-off or recurring losses.
• Weak operating efficiency: operating margin sits at 1.15%, indicating minimal buffer to absorb cost shocks or revenue volatility.
• Negative asset returns: return on assets (ROA) is -0.06%, implying underutilization or impairment of assets relative to earnings.
• High valuation multiple: enterprise value to EBITDA (EV/EBITDA) stands at 75.13, which may suggest market overvaluation or depressed EBITDA driving the ratio up.
• Leverage concerns: total debt equals $3.39 billion as of March 31, 2025, heightening refinancing, interest-rate and covenant risks.

• Cash flow vulnerability: given the steep revenue and net-income declines, operating cash flow is likely strained, increasing reliance on external financing or asset disposals.
• Interest and liquidity risk: with $3.39B debt, rising rates or tightened credit markets could force costly refinancing or covenant breaches.
• Valuation mismatch: a 75.13 EV/EBITDA suggests investors should scrutinize whether market capitalization reflects recoverable earnings or a short-term EBITDA trough.
• Operational and asset risk: low operating margin and negative ROA point to potential inefficiencies, asset write-down risk, or poor capital allocation.
• Event risk: such extreme year-over-year declines in net income (‑95.98%) may be driven by one-off charges, litigation, asset impairment, or sector-specific shocks that can recur.

Xiamen ITG Group Corp.,Ltd (600755.SS) Growth Opportunities

Xiamen ITG Group's strategic pivot toward health technology and advanced manufacturing is producing measurable revenue growth and positions the company to leverage supply-chain innovation, digitalization, and low-carbon initiatives tied to its controlling shareholder's ambition to build a world-class enterprise.

• Health technology segment grew 49.61% in 2024, contributing ¥1.10 billion to total revenue.
• Company strategy emphasizes expansion into health technology and advanced manufacturing to capture higher-margin, high-growth markets.
• Recognized as a national supply chain innovation and application demonstration enterprise - a credibility boost for supply-chain services expansion.
• Active integration of digital intelligence and green development across supply-chain services aimed at low-carbon transformation.
• Market capitalization: ¥13.85 billion (as of 12-Dec-2025), reflecting market position and scale.
• Consensus mean target price: ¥7.500, implying potential upside relative to the prevailing market price.

Key levers for near- to medium-term growth:

• Scaling the health technology business where the 49.61% growth and ¥1.10B revenue base provide momentum.
• Commercializing supply-chain innovation services under the national demonstration designation to win larger enterprise contracts.
• Leveraging digital intelligence to improve margins, logistics efficiency, and traceability across group supply chains.
• Pursuing low-carbon transformation to access green procurement channels and policy incentives.
• Aligning capital allocation and M&A (if any) to build advanced manufacturing capabilities consistent with the controlling shareholder's world-class enterprise goal.

Further context on corporate history, ownership and strategic rationale: Xiamen ITG Group Corp.,Ltd: History, Ownership, Mission, How It Works & Makes Money